Cardiovascular disease is the leading cause of death in women, and stress-related psychiatric disorders are considered cardiovascular risk factors in their own right. Hormonal contraceptives, which are used by around 9 million women in the USA, have a heterogeneous cardiovascular effect profile. A retrospective cohort study published in JAMA Network Open in January 2026 is the first to systematically investigate how post-traumatic stress disorder (PTSD), depression and anxiety disorders influence the association between combined hormonal contraception and serious cardiovascular events and deep vein thrombosis.
You May Also Like
- Cardiology and Nutrition
Ultra-Processed Foods and Cardiovascular Risk—The New AHA Position Statement
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- Breast (HR+) and Endometrial Cancer
A Comparison of Hormone-Dependent Female Tumors
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations